Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -95.45% | 10.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -95.45% | 10.76% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -95.45% | 10.76% | |||
| SG&A Expenses | 17.19% | -14.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.12% | 16.63% | |||
| Operating Income | 11.00% | -16.78% | |||
| Income Before Tax | -15.89% | -8.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.89% | -8.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.89% | -8.04% | |||
| EBIT | 11.00% | -16.78% | |||
| EBITDA | 10.97% | -18.64% | |||
| EPS Basic | 0.23% | 1.58% | |||
| Normalized Basic EPS | -4.94% | 9.40% | |||
| EPS Diluted | 0.28% | 1.53% | |||
| Normalized Diluted EPS | -4.94% | 9.40% | |||
| Average Basic Shares Outstanding | 16.16% | 9.77% | |||
| Average Diluted Shares Outstanding | 16.16% | 9.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||